Investor Type
Fu Haiying is the Head of the biopharmaceutical team at Wuxi Capital.
Overview
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 Genesis Medtech |  Wuxi Capital | Series C - Genesis Medtech | |||
 Yindatong | Wuxi Capital | Seed Round - Yindatong | |||
 Hope Medicine | Wuxi Capital | Series B - Hope Medicine |
Recent News and Activity
There is no recent news or activity for this profile.
